News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,234 Results
Type
Article (66498)
Company Profile (366)
Press Release (662370)
Multimedia
Podcasts (106)
Webinars (12)
Section
Business (206354)
Career Advice (2437)
Deals (34778)
Drug Delivery (104)
Drug Development (83674)
Employer Resources (154)
FDA (16439)
Job Trends (15098)
News (348225)
Policy (31630)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (10)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (14)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2896)
Academic (2)
Accelerated approval (6)
Adcomms (17)
Allergies (84)
Alliances (53035)
ALS (94)
Alzheimer's disease (1458)
Antibody-drug conjugate (ADC) (135)
Approvals (16429)
Artificial intelligence (272)
Autoimmune disease (24)
Automation (13)
Bankruptcy (307)
Best Places to Work (11707)
BIOSECURE Act (20)
Biosimilars (98)
Biotechnology (247)
Bladder cancer (63)
Brain cancer (30)
Breast cancer (269)
Cancer (2154)
Cardiovascular disease (183)
Career advice (2045)
Career pathing (31)
CAR-T (154)
Cell therapy (444)
Cervical cancer (21)
Clinical research (67170)
Collaboration (841)
Compensation (470)
Complete response letters (23)
COVID-19 (2793)
CRISPR (43)
C-suite (236)
Cystic fibrosis (103)
Data (2064)
Decentralized trials (2)
Denatured (39)
Depression (50)
Diabetes (259)
Diagnostics (6533)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (126)
Drug pricing (92)
Drug shortages (24)
Duchenne muscular dystrophy (90)
Earnings (82041)
Editorial (39)
Employer branding (21)
Employer resources (136)
Events (115286)
Executive appointments (704)
FDA (17616)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (742)
Gene editing (108)
Generative AI (28)
Gene therapy (312)
GLP-1 (761)
Government (4235)
Grass and pollen (4)
Guidances (49)
Healthcare (19045)
Huntington's disease (22)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2944)
Inflammatory bowel disease (144)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (93)
Interviews (436)
IPO (16517)
IRA (45)
Job creations (3862)
Job search strategy (1747)
Kidney cancer (9)
Labor market (28)
Layoffs (493)
Leadership (18)
Legal (7220)
Liver cancer (74)
Lung cancer (304)
Lymphoma (136)
Machine learning (5)
Management (51)
Manufacturing (301)
MASH (66)
Medical device (13720)
Medtech (13724)
Mergers & acquisitions (18812)
Metabolic disorders (690)
Multiple sclerosis (76)
NASH (19)
Neurodegenerative disease (100)
Neuropsychiatric disorders (29)
Neuroscience (2003)
NextGen: Class of 2025 (6560)
Non-profit (4665)
Northern California (2505)
Now hiring (29)
Obesity (365)
Opinion (249)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (81)
Parkinson's disease (151)
Partnered (22)
Patents (223)
Patient recruitment (101)
Peanut (48)
People (59410)
Pharmaceutical (88)
Pharmacy benefit managers (12)
Phase I (20967)
Phase II (29458)
Phase III (22019)
Pipeline (1126)
Policy (131)
Postmarket research (2883)
Preclinical (9423)
Press Release (72)
Prostate cancer (101)
Psychedelics (36)
Radiopharmaceuticals (266)
Rare diseases (387)
Real estate (6243)
Recruiting (62)
Regulatory (22246)
Reports (35)
Research institute (2627)
Resumes & cover letters (366)
Rett syndrome (4)
RNA editing (4)
RSV (46)
Schizophrenia (76)
Series A (133)
Series B (82)
Service/supplier (17)
Sickle cell disease (51)
Southern California (2186)
Special edition (17)
Spinal muscular atrophy (156)
Sponsored (32)
Startups (3824)
State (1)
Stomach cancer (15)
Supply chain (63)
Tariffs (19)
The Weekly (65)
United States (22196)
Vaccines (763)
Venture capitalists (34)
Weight loss (257)
Women's health (35)
Worklife (17)
Date
Today (11)
Last 7 days (490)
Last 30 days (2370)
Last 365 days (34219)
2025 (9184)
2024 (36488)
2023 (41379)
2022 (52662)
2021 (57168)
2020 (55292)
2019 (47555)
2018 (36130)
2017 (34330)
2016 (34279)
2015 (40482)
2014 (33709)
2013 (29653)
2012 (30553)
2011 (30709)
2010 (29025)
Location
Africa (960)
Alabama (58)
Alaska (7)
Arizona (201)
Arkansas (13)
Asia (43796)
Australia (7665)
California (5765)
Canada (1907)
China (510)
Colorado (254)
Connecticut (275)
Delaware (131)
Europe (100169)
Florida (850)
Georgia (203)
Hawaii (1)
Idaho (47)
Illinois (515)
India (27)
Indiana (306)
Iowa (7)
Japan (151)
Kansas (107)
Kentucky (21)
Louisiana (12)
Maine (69)
Maryland (870)
Massachusetts (4434)
Michigan (228)
Minnesota (389)
Mississippi (2)
Missouri (79)
Montana (30)
Nebraska (25)
Nevada (56)
New Hampshire (69)
New Jersey (1660)
New Mexico (31)
New York (1644)
North Carolina (1026)
North Dakota (7)
Northern California (2505)
Ohio (202)
Oklahoma (14)
Oregon (35)
Pennsylvania (1266)
Puerto Rico (11)
Rhode Island (26)
South America (1263)
South Carolina (19)
Southern California (2186)
Tennessee (91)
Texas (857)
Utah (173)
Virginia (148)
Washington D.C. (60)
Washington State (550)
West Virginia (2)
Wisconsin (58)
729,234 Results for "rinat pfizer global research and development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Pfizer’s Pipeline Pruning Ends Early-Stage STING Trial
Pfizer was studying PF-07820435, an orally available agonist of the STING protein, for solid tumors.
March 14, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
How SpringWorks Took Pfizer’s Rare Disease Ghost Drug and Got It to Patients
SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under the sun,” advocates say.
February 26, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Press Releases
Pfizer Announces New Chief Scientific Officer and President, Research & Development
November 20, 2024
·
8 min read
Vaccines
UK Patent Win Over GSK Boosts Pfizer in Global RSV Vaccine Fight
A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ongoing legal clashes in other parts of the world.
November 20, 2024
·
4 min read
·
Nick Paul Taylor
Gene therapy
Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia
The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.
February 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
MicuRx: 15 Clinical and Preclinical Research Studies to be Presented at ESCMID Global 2025
April 8, 2025
·
1 min read
Business
Pfizer Gets Breather From Starboard’s Ongoing Assault
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by its current leadership. But
Bloomberg
reports it has missed the deadline for nominating a director to the pharma’s board.
January 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
March 12, 2025
·
8 min read
Sickle cell disease
Pfizer Takes Sickle Cell Drug Oxbryta Off Global Market, Cites Risk of Death
Based on new safety signals, Pfizer on Wednesday announced that Oxbryta’s overall benefit “no longer outweighs the risk” in patients with sickle cell disease. Guggenheim Securities analysts said the setback increases investor frustrations with the company’s business development track record.
September 26, 2024
·
2 min read
·
Tristan Manalac
1 of 72,924
Next
